Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVXT Solution in Mild-to-Moderate Onychomycosis
NCT02343627Phase 2Completed
- Start
- Dec 2014
- Primary completion
- Jan 2016
01
Overview
Phase 2, randomised, double-blind trial in onychomycosis (2 arms). Primary endpoint: Number of Participants With Negative Fungal Culture at 28 days. Started Dec 2014; status: completed.
02
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT02343627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02343627.